Decades of research show the mercury-containing preservative thimerosal is safe in vaccines, but CDC's new advisory panel is ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

You could be forgiven if you believed that the FDA granted full approval to Moderna's COVID-19 vaccines for children yesterday. Indeed, that's how many major media outlets portrayed things. After all, ...

A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...

Advisers to the Centers for Disease Control and Prevention recommended against flu shots containing the ingredient thimerosal ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

The preservative is in a small share of flu shots and has been studied for decades. Experts say it’s safe — despite Kennedy’s long opposition.

The Trump administration’s new vaccine advisers endorsed this fall's flu vaccines late last week, but only those that don't contain the ingredient thimerosal.

The long and winding journey of Moderna’s mRNA flu vaccine toward regulators has come one step closer with a phase 3 win over an approved competitor.

Moderna's voluntary withdrawal of the filing stems from the FDA's request for vaccine efficacy data from a phase III study on the experimental flu shot.

Ultimately, VRBPAC focused largely on existing COVID-19 vaccines’ ability to neutralize the virus and unanimously recommended that next season’s vaccine should target the JN.1 variant.